CME vs PATH · P/E 22, rev $6.52B vs P/E 19, rev $1.61B
CME Group Inc (CME) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported CME revenue for 2025-12-31 was $6.52B. Net income was $4.07B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
CME currently screens at market cap $91.25B and trailing P/E 21.9. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the CME and PATH stock pages for the full models.
Not investment advice.